Strongest evidence
The most robust finding is for increased 25-hydroxyvitamin D levels (high evidence strength, 14 of 16 studies beneficial, doses 240–4000 IU/day). Moderate evidence supports benefits for improved insulin sensitivity (6 of 9 studies, 1000–4000 IU/day, especially in vitamin D-deficient individuals), reduced inflammation (5 of 5 studies, small effect), improved quality of life (7 of 8 studies, 4000 IU/day or 60,000 IU/week), reduced triglycerides (5 of 8 studies, small effect in metabolic disorders), and reduced C-reactive protein (5 of 8 studies, moderate effect at 8–16 weeks).
Mixed or weaker evidence
Several outcomes show moderate evidence with notable neutral results: reduced blood cholesterol (3 of 8 studies beneficial), reduced HOMA-IR (3 of 5 meta-analyses beneficial), and reduced tumor necrosis factor alpha (3 of 5 studies beneficial). The evidence for reduced depression symptoms is preliminary (3 of 4 studies beneficial, small effect). No outcomes in the top syntheses reached low/very low evidence strength.
Effective dose patterns
Across multiple outcomes, effective doses converged around 1000–4000 IU/day for daily supplementation. For weekly dosing, 60,000 IU/week was used in quality of life studies. Single high-dose boluses up to 50,000 IU were also employed for raising 25-hydroxyvitamin D levels, but most beneficial effects on downstream outcomes emerged with sustained daily dosing over 8–12 weeks.
Population insights
Benefits consistently appeared stronger in vitamin D-deficient populations and in clinical subgroups (e.g., women with PCOS, gestational diabetes, type 2 diabetes, metabolic disorders, and inflammatory conditions). Effects were often modest or absent in healthy, replete individuals. Specific caveats noted for phenylketonuria patients and kidney transplant recipients (neutral effects on 25-hydroxyvitamin D levels).
Notable caveats
Publication bias is a concern across multiple outcomes—null-result studies are less likely to be published. Most evidence comes from clinical populations, limiting generalizability to healthy adults. Many studies did not consistently report supplement form (D2 vs. D3) or combined vitamin D with other supplements (e.g., magnesium), complicating isolation of vitamin D's independent effect.